February 1, 2017
Health Economic Modeling

Thermo Fisher Scientific: safely reduce antibiotic exposure

Antibiotics are a limited resource. At the current pace of injudicious use, all antibiotics will soon become ineffective. Panaxea together with Thermo Fisher developed a health-economic model for the use of Procalcitonin (PCT) to determine whether PCT can cost-effectively reduce the use of antibiotics for sepsis. This brochure displays among other […]
August 17, 2016
Health Care Innovations

Panaxea joins Flanders Innovation & Entrepreneurship

We’re proud to announce that Panaxea is now a certified service provider for the Flemish government under the SME grants from the Flanders Innovation & Enterpreneurship agency ( http://www.kmo-portefeuille.be/). Flanders Innovation & Entrepreneurship (in Dutch: Agentschap Innoveren & Ondernemen) is a government agency, charged with implementing the economic, innovation and enterprise policy in […]
June 3, 2015
diagnostic innovation

Articulating the value of diagnostics

Diagnostics face difficulties in current market conditions to obtain reimbursement and to enter the market efficiently. This white paper highlights the challenges, but more importantly also highlights the opportunities in articulating the value of diagnostics. It is explained why tailored health economic evidence is paramount to show the value of […]
May 19, 2015
Cost effective health model

Generic decision model for diagnostic tests

To give (potential) clients a preliminary insight in the cost-effectiveness of their diagnostic test, we developed an online generic decision model. This model allows users to compare the cost and effects of a diagnostic test versus not testing by using data they collected themselves, for example data they collected during […]
March 31, 2015
Panaxea Courses

Courses

Building upon our expertise and experience, Panaxea can organize or contribute to courses, seminars and workshops on a wide range of topics in the field of health technology assessment. For this, we can build on years of experience in teaching to students of the University of Twente. In particular, Panaxea […]
February 25, 2015

Systematic literature review

For a medical device company developing blood glucose meters, we performed a systematic literature review on self-monitoring of blood glucose levels among patients with type 2 diabetes. The report covered an analysis of the burden of the disease and the cost-effectiveness of blood glucose self-monitoring. Cost tables, specifying the cost […]
February 25, 2015
Cost effective health model

Market access and reimbursement report

A medical device company has developed a new technology that could improve the visualization and treatment of the affected heart tissue during catheter ablations of the left atrium of the heart. They were interested in getting an overview of the market access and reimbursement regulations in the Netherlands and Belgium […]
February 25, 2015
Health Technology Assessment

Cost-effectiveness and budget impact model for a diagnostic test

Allergic Rhinitis (AR) is a condition where an inflammatory reaction of the immune system is caused by specific allergens. Respiratory AR affects around 15% of the people in the Netherlands. Mostly, AR is treated with symptomatic treatment, but immunotherapy potentially offers a curative treatment by minimizing sensitivity to the allergen. […]
January 22, 2014

Health economic modeling

For a global health company we evaluated the expected incremental cost-effectiveness of one of their products. The cost-effectiveness outcome was needed to support adjuvant therapy decision making versus current clinical practice in the Netherlands. We… developed a Markov model to project distant recurrences survival, quality-adjusted life expectancy and direct medical […]